Simplex Trading’s Coya Therapeutics COYA Stock Holding History

Simplex Trading’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-119	Closed	-$723	–	8760
2025 Q3	$0	Buy	+119	New	+$724	﹤0.01%	9186

Other funds holding COYA

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Simplex Trading's COYA Position: Q4 2025 in Review

Simplex Trading sold out of Coya Therapeutics (COYA) in Q4 2025, closing a stake of 119 shares — an estimated $723 sold.

Simplex Trading first reported a position in COYA in Q3 2025 and held it in 1 quarter. The position peaked at $0 in Q3 2025. 58 funds tracked by Wall St. Rank hold COYA as of Q4 2025.

Simplex Trading reported no remaining Coya Therapeutics position as of Q4 2025 after selling out during the quarter.
Simplex Trading sold 119 Coya Therapeutics shares in Q4 2025, an estimated $723.
Simplex Trading first reported a position in Coya Therapeutics in Q3 2025 and held it in 1 quarter.
Simplex Trading's Coya Therapeutics position peaked at $0 in Q3 2025.
58 funds tracked by Wall St. Rank held Coya Therapeutics as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.